Bay Area Life Sciences Vacancy Jumps to 26.2% as Pfizer Vacates 164,000 SQFT at Oyster Point and Emeryville Land Sells for Half Its 2019 Price
Why this matters
The sharp rise in Bay Area life sciences vacancy to over 26 percent, coupled with Pfizer’s sizeable lab space exit and a significant markdown in Emeryville land prices, signals a notable recalibration in a sector long viewed as a defensive growth play. The surge in vacancy, driven by a wave of new supply exceeding immediate demand, suggests that the market’s absorption capacity is under strain. Pfizer’s departure from a large footprint underscores potential tenant consolidation or strategic repositioning amid broader industry headwinds, such as funding volatility or shifting R&D priorities. The halving of land values since 2019 in a core innovation hub further reflects a reassessment of future growth prospects and risk tolerance among institutional investors and developers. This price correction may temper speculative land plays and slow new project pipelines, but also opens a window for capital with patient horizons to acquire strategic sites at more disciplined valuations. Overall, these developments highlight a transitional phase for Bay Area life sciences real estate, where capital flows and underwriting assumptions are adjusting to a more cautious outlook. Allocators should monitor whether this oversupply and tenant flight are localized or indicative of wider sector stress, as well as the implications for financing conditions and portfolio positioning in innovation districts.
Editorial analysis · AI-assisted
On the RET wire
- The 39th San Francisco story tracked on the wire in July 2026. All San Francisco coverage →
- Disclosed land deal value tracked in July 2026: $587.2M across 4 reported transactions. All Land coverage →
Computed from Real Estate Trail’s own tracked coverage
The San Francisco Bay Area’s life sciences vacancy rate climbed 310 basis points year over year to 26.2 percent as more than 500,000 square feet of new lab space delivered into a market where Pfizer is emptying a 164,…
External link. Real Estate Trail does not republish source content.
Related coverage — San Francisco · Land
Ridge Capital Takes 272,000 SQFT 201 California in San Francisco From Columbia Property Trust for $75MM, Backed by $80.1MM Rialto Loan
Ridge Capital Investors closed on the 17-story 201 California Street tower in San Francisco's Financial District for $75 million in July, financing the purchase with a loan of up to $80.1 million from a Rialto Capital…
The Registry Ranks: Where the Bay Area Lab Rebound Will Actually Show Up First
Bay Area life science vacancy sits near 29% and the construction pipeline is at zero, but the pain is wildly uneven. Here is our tier list of the five lab markets, ranked for investors betting on a 2027 rebound. The p…
On Ice Rinks Brings 6,000 SQFT Holiday Ice Rink to Port’s Triangle Lot at Fisherman’s Wharf in San Francisco
San Francisco on Ice, which can hold 125 skaters per session, will run from Nov. 4 through Jan. 18 next to the SkyStar Wheel, giving the city its first new outdoor rink since the Embarcadero Center rink closed nearly…
San Francisco office leasing topped its pre-pandemic level amid a boom in AI-driven leasing by tech firms.
Owner That Took 132,000 SQFT 2101 Mission From Deutsche Bank Debt Brings Former Thrift Town Building to Market in San Francisco
2101 MS Property Holdings LLC, which acquired Deutsche Bank's position on a loan of up to $75.8 million and took title to the former Thrift Town building at 17th and Mission streets in April 2025, is calling for offer…
Grosvenor Puts 101,000 SQFT 560 South Winchester Office Building Beside Santana Row Up for Sale After 13-Year Hold in San Jose
Grosvenor Americas is calling for offers on 560 South Winchester, a six-story, LEED Gold office building on the Santana Row block that it bought for $47.1 million in 2013 and that Santa Clara County now assesses at ro…